Yong-Kun Wang
Overview
Explore the profile of Yong-Kun Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji W, Wang Y, Han Z, Wang S, Wang Y
Front Oncol
. 2025 Jan;
14:1474891.
PMID: 39759150
Objectives: to construct a prediction model for clinically significant prostate cancer (csPCa) based on prostate-specific antigen (PSA) levels, digital rectal examination (DRE), and transrectal ultrasonography (TRUS). Methods: We retrospectively analysed...
2.
Wang Y, Lu N, Wang P
PLoS One
. 2024 Sep;
19(9):e0311097.
PMID: 39331690
Data indicate that carbon dioxide emissions from residential buildings in China constitute 60% of the country's total, making carbon reduction efforts in residential construction crucial for achieving dual carbon goals....
3.
Li D, Chen W, Luo L, Wang Y, Shang J, Zhang Y, et al.
Int J Mol Med
. 2017 Oct;
40(6):1895-1906.
PMID: 29039552
Accumulating evidence suggests that the dysregulation of long non-coding RNAs (lncRNAs) serves vital roles in the incidence and progression of lung cancer. However, the molecular mechanisms of LINC00968, a recently...
4.
Lu X, Li C, Wang Y, Jiang K, Gai X
Oncol Lett
. 2014 Jun;
7(6):1992-1996.
PMID: 24932277
Sorbitol has been reported to have anticancer effects in several tumor models, however its effects on colorectal cancer remain elusive. In the present study, the effects of sorbitol on growth...
5.
Chen J, Huang S, Wu K, Wang Y, Jia Y, Lu Y, et al.
Zhonghua Wai Ke Za Zhi
. 2013 Nov;
51(7):641-4.
PMID: 24256593
Objectives: To evaluate the expression of synuclein-γ (SNCG) and metalloproteinase 9 (MMP-9) both in the invasive ductal breast cancer samples and T47D and T47D(SNCG)- cell lines, to investigate the correlation...
6.
Wang C, Tang L, Shen D, Wang C, Yuan Q, Gao W, et al.
Mol Biol Rep
. 2013 Oct;
40(12):6525-31.
PMID: 24154762
Hepatocellular carcinoma is a primary malignancy of hepatocytes which accounts for 80 % of all primary liver cancers. DFNA5 has been identified as a tumor suppressor gene with an important...
7.
Wang C, Wang C, Han J, Wang Y, Tang L, Shen D, et al.
Mol Biol Rep
. 2013 Oct;
40(12):6579-85.
PMID: 24135803
This study aimed to evaluate the efficacy of combined treatment with recombinant interleukin-2 (rIL-2) and allicin on pancreatic cancer and explore the potential immunological mechanism. A total of 60 C57/BL6...
8.
Wang C, Xu R, Yuan Q, Wang Y, Shen D, Wang X, et al.
J Comput Biol
. 2013 Apr;
20(6):444-52.
PMID: 23614574
Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98% due to widespread metastatic disease. A better understanding of the molecular mechanism of pancreatic cancer is beneficial for...
9.
Zhao Y, Jian W, Gao W, Zheng Y, Wang Y, Zhou Z, et al.
Cancer Cell Int
. 2013 Mar;
13(1):23.
PMID: 23497309
Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Although much is known about both the cellular changes that lead to HCC and the etiological agents responsible...
10.
Wang Y, Han J, Xiong W, Yuan Q, Gu Y, Li J, et al.
Molecules
. 2012 Aug;
17(9):10267-75.
PMID: 22926307
Oxidative stress is involved in the development and progression of disease. Because sodium aescinate has been reported to have immunity enhancing and antioxidative effects, we investigated its activity by employing...